Georgia-based Deerland Enzymes has opened a new enzyme development laboratory that increased its capabilities in quality assurance, R&D as well as application development and technical support.

Deerland has dedicated space in the lab facility with restricted entry to support highly confidential product development, ensuring high level of safety and security in terms of protecting the intellectual properties of clients, said CEO Scott Ravech.

The new lab will have continued focus on quality, accuracy and GMP Compliance, said the company.

Deerland Enzymes is an international trading and enzyme manufacturing company, offering a wide spectrum of plant, animal, fungal and bacterial-sourced enzymes used by a slew of industries including food, nutritional supplements, brewing, distilling and animal feed, starch, textiles, waste treatment, paper and pharmaceuticals.